Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Schools, offices in some towns, districts to close Saturday
07/26/2024 10:51 PM - Society
Magnitude 4.6 earthquake shakes Pingtung
07/26/2024 10:30 PM - Politics
Mayor, lawmaker convicted of corruption face different outcomes
07/26/2024 10:02 PM - Society
Typhoon Gaemi causes 8 deaths, 866 injuries as of Friday night
07/26/2024 09:58 PM - Politics
Taichung mayor to resume U.S. trip after typhoon
07/26/2024 09:57 PM